We are live on ! Find out more
Troluce Capital Advisors

Troluce Capital Advisors Portfolio holdings

AUM $971M Turnover 94.44%
1-Year Est. Return 2.27%
This Fund
S&P 500
This Quarter Est. Return
-6.63%
1 Year Est. Return
+2.27%
3 Year Est. Return
+61.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$971M
AUM Growth
-$660M
Cap. Flow
-$635M
Cap. Flow %
-65.37%
Top 10 Hldgs %
88.66%
Holding
90
New
21
Increased
3
Reduced
2
Closed
64
Avg Time Held Equity + Options
0.1 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
0.1 years
Top 10 Avg Time Held Equity only
0.1 years
Top 20 Avg Time Held Equity only
0.1 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 72.51%
2 Industrials 14.82%
3 Healthcare 6.49%
4 Communication Services 5.68%
5 Technology 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$77.8B
$300M 30.94%
+1,000,000
New +$281M
2026 Q2
0 quarters
SPCX icon
2
PUT
SpaceX
SPCX
$1.95T
$167M 17.16%
+975,000
New +$166M
2026 Q2
0 quarters
ECHO icon
3
CALL
EchoStar
ECHO
$25.1B
$86.3M 8.89%
+850,000
New +$104M
2026 Q2
0 quarters
AMTM icon
4
Amentum Holdings
AMTM
$4.76B
$73.7M 7.59%
3,565,399
+2,565,399
+257% +$62M
2026 Q1
1 quarter
ECHO icon
5
EchoStar
ECHO
$25.1B
$55.2M 5.68%
543,602
-56,398
-9% -$6.89M
2026 Q1
1 quarter
MLYS icon
6
Mineralys Therapeutics
MLYS
$1.85B
$46.6M 4.8%
1,728,753
+1,073,753
+164% +$29.5M
2026 Q1
1 quarter
GSAT icon
7
PUT
Globalstar
GSAT
$10.8B
$40.6M 4.19%
+500,000
New +$40.2M
2026 Q2
0 quarters
XBI icon
8
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$39.6M 4.07%
+250,000
New +$33.8M
2026 Q2
0 quarters
MIR icon
9
Mirion Technologies
MIR
$3.72B
$27.6M 2.84%
1,539,212
+39,212
+3% +$727K
2025 Q4
2 quarters
AEIS icon
10
Advanced Energy
AEIS
$9.6B
$24.2M 2.5%
+65,000
New +$22.7M
2026 Q2
0 quarters
GSAT icon
11
CALL
Globalstar
GSAT
$10.8B
$19.1M 1.97%
+235,400
New +$18.9M
2026 Q2
0 quarters
STOK icon
12
Stoke Therapeutics
STOK
$1.6B
$16.2M 1.67%
496,416
-156,384
-24% -$5.02M
2026 Q1
1 quarter
TKR icon
13
CALL
Timken Company
TKR
$7.81B
$14.3M 1.47%
+98,400
New +$11.8M
2026 Q2
0 quarters
AMZN icon
14
CALL
Amazon
AMZN
$2.83T
$11.9M 1.23%
+50,000
New +$12.6M
2026 Q2
0 quarters
GD icon
15
General Dynamics
GD
$92.4B
$9.7M 0.99%
+27,250
New +$9.33M
2026 Q2
0 quarters
NRG icon
16
CALL
NRG Energy
NRG
$20.9B
$8.54M 0.88%
+58,500
New +$8.42M
2026 Q2
0 quarters
BBIO icon
17
CALL
BridgeBio Pharma
BBIO
$13.3B
$7.45M 0.77%
+100,000
New +$7M
2026 Q2
0 quarters
Q icon
18
Qnity Electronics Inc
Q
$24.9B
$4.92M 0.51%
+30,100
New +$4.43M
2026 Q2
0 quarters
ENTG icon
19
CALL
Entegris
ENTG
$22.1B
$4.42M 0.46%
+24,600
New +$3.55M
2026 Q2
0 quarters
HON icon
20
Honeywell
HON
$66.6B
$3.74M 0.39%
+16,700
New +$3.73M
2026 Q2
0 quarters
QXO icon
21
QXO Inc
QXO
$10.5B
$3.46M 0.36%
+200,000
New +$3.72M
2026 Q2
0 quarters
FOXA icon
22
CALL
Fox Class A
FOXA
$27.5B
$3.23M 0.33%
+62,000
New +$3.83M
2026 Q2
0 quarters
INIO icon
23
INNIO N.V.
INIO
$12B
$1.48M 0.15%
+37,500
New +$1.34M
2026 Q2
0 quarters
MLYS icon
24
CALL
Mineralys Therapeutics
MLYS
$1.85B
$1.35M 0.14%
+50,000
New +$1.37M
2026 Q2
0 quarters
WBD icon
25
CALL
DELISTED
Warner Bros
WBD
$141K 0.01%
+5,300
New +$143K
2026 Q2
0 quarters

Similar funds

Troluce Capital Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Troluce Capital Advisors held 90 positions worth $971M, down 40% from $1.63B the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Troluce Capital Advisors withdrew a net $635M in Q2 2026, closing 64 positions and reducing 2 holdings. Its most notable exit was Atlanta Braves Holdings Series B, an estimated $85.4M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 73% of assets, up from 42% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Troluce Capital Advisors opened a new position in Advanced Energy worth $24.2M.

  • Troluce Capital Advisors's largest Q2 2026 buy was Advanced Energy: 65,000 shares worth $24.2M.
  • Troluce Capital Advisors added most to Amentum Holdings in Q2 2026, an estimated $62M increase.
  • Troluce Capital Advisors's biggest Q2 2026 reduction was EchoStar, cutting an estimated $6.89M.
  • Troluce Capital Advisors fully exited Atlanta Braves Holdings Series B in Q2 2026, selling an estimated $85.4M.
  • Troluce Capital Advisors's ten largest holdings make up 89% of its $971M portfolio in Q2 2026.
  • Troluce Capital Advisors opened 21 new positions and closed 64 in Q2 2026.
  • Troluce Capital Advisors's portfolio value fell 40% quarter-over-quarter to $971M.

Based on Troluce Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.